Seeking Alpha

FDA approves Novo Nordisk insulin pens

  • The FDA approves Novo Nordisk's (NVO) NovoRapid FlexTouch and Levemir FlexTouch prefilled insulin pens.
  • The company plans to make the pens available in the U.S. "within the next year." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs